| Title |
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents
|
|---|---|
| Published in |
Psychopharmacology, March 2010
|
| DOI | 10.1007/s00213-010-1827-6 |
| Pubmed ID | |
| Authors |
D. Matthew Walentiny, Robert E. Vann, Jonathan A. Warner, Lindsey S. King, Herbert H. Seltzman, Hernán A. Navarro, Charles E. Twine, Brian F. Thomas, Anne F. Gilliam, Brian P. Gilmour, F. Ivy Carroll, Jenny L. Wiley |
| Abstract |
Salvinorin A, the primary psychoactive derivative of the hallucinogenic herb Salvia divinorum, is a potent and highly selective kappa-opioid receptor (KOR) agonist. Several recent studies, however, have suggested endocannabinoid system mediation of some of its effects. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 2% |
| United States | 1 | 2% |
| Unknown | 52 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 26% |
| Student > Ph. D. Student | 11 | 20% |
| Student > Bachelor | 7 | 13% |
| Student > Master | 5 | 9% |
| Other | 4 | 7% |
| Other | 6 | 11% |
| Unknown | 7 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 10 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 15% |
| Medicine and Dentistry | 7 | 13% |
| Psychology | 5 | 9% |
| Chemistry | 5 | 9% |
| Other | 8 | 15% |
| Unknown | 11 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2021.
All research outputs
#7,444,248
of 24,494,826 outputs
Outputs from Psychopharmacology
#2,056
of 5,549 outputs
Outputs of similar age
#34,317
of 99,617 outputs
Outputs of similar age from Psychopharmacology
#19
of 41 outputs
Altmetric has tracked 24,494,826 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 5,549 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 99,617 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.